Shirley R. Kuhlmann is EVP and General Counsel of COLLEGIUM PHARMACEUTICAL, INC. Currently has a direct ownership of 119,184 shares of COLL, which is worth approximately $3.67 Million. The most recent transaction as insider was on Sep 06, 2024, when has been sold 977 shares (Common Stock) at a price of $37.46 per share, resulting in proceeds of $36,598. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 119K
14.51% 3M change
0.28% 12M change
Total Value Held $3.67 Million

Shirley R. Kuhlmann Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 06 2024
SELL
Open market or private sale
$36,598 $37.46 p/Share
977 Reduced 0.81%
119,184 Common Stock
Sep 05 2024
SELL
Open market or private sale
$744,127 $38.66 p/Share
19,248 Reduced 13.81%
120,161 Common Stock
Jun 03 2024
SELL
Open market or private sale
$822,250 $32.89 p/Share
25,000 Reduced 15.21%
139,409 Common Stock
Feb 12 2024
SELL
Payment of exercise price or tax liability
$1,070,177 $33.7 p/Share
31,756 Reduced 16.19%
164,409 Common Stock
Feb 12 2024
BUY
Grant, award, or other acquisition
-
76,647 Added 28.1%
196,165 Common Stock
Nov 27 2023
SELL
Open market or private sale
$659,968 $25.78 p/Share
25,600 Reduced 17.64%
119,518 Common Stock
Nov 27 2023
BUY
Exercise of conversion of derivative security
$407,040 $15.9 p/Share
25,600 Added 15.0%
145,118 Common Stock
Jun 26 2023
SELL
Open market or private sale
$397,266 $22.09 p/Share
17,984 Reduced 13.08%
119,518 Common Stock
Feb 13 2023
SELL
Open market or private sale
$586,279 $26.88 p/Share
21,811 Reduced 13.69%
137,502 Common Stock
Feb 10 2023
SELL
Payment of exercise price or tax liability
$643,230 $26.75 p/Share
24,046 Reduced 13.11%
159,313 Common Stock
Feb 10 2023
BUY
Grant, award, or other acquisition
-
73,864 Added 28.72%
183,359 Common Stock
Sep 15 2022
SELL
Open market or private sale
$697,303 $18.07 p/Share
38,589 Reduced 26.06%
109,495 Common Stock
Aug 11 2022
SELL
Open market or private sale
$6,003 $20.01 p/Share
300 Reduced 0.2%
148,084 Common Stock
Mar 16 2022
SELL
Payment of exercise price or tax liability
$13,939 $18.99 p/Share
734 Reduced 0.49%
148,384 Common Stock
Feb 10 2022
SELL
Payment of exercise price or tax liability
$197,086 $17.63 p/Share
11,179 Reduced 6.97%
149,118 Common Stock
Feb 10 2022
BUY
Grant, award, or other acquisition
-
71,041 Added 30.71%
160,297 Common Stock
Sep 16 2021
SELL
Payment of exercise price or tax liability
$14,438 $19.67 p/Share
734 Reduced 0.82%
89,256 Common Stock
May 10 2021
SELL
Open market or private sale
$159,390 $22.77 p/Share
7,000 Reduced 7.22%
89,990 Common Stock
Mar 16 2021
SELL
Payment of exercise price or tax liability
$18,122 $24.69 p/Share
734 Reduced 0.75%
96,990 Common Stock
Feb 10 2021
SELL
Payment of exercise price or tax liability
$152,015 $25.95 p/Share
5,858 Reduced 5.66%
97,724 Common Stock
Jan 20 2021
SELL
Open market or private sale
$148,680 $24.45 p/Share
6,081 Reduced 5.55%
103,582 Common Stock
Jan 19 2021
BUY
Grant, award, or other acquisition
-
52,132 Added 32.22%
109,663 Common Stock
Oct 15 2020
SELL
Open market or private sale
$146,989 $20.82 p/Share
7,060 Reduced 10.93%
57,531 Common Stock
SRK

Shirley R. Kuhlmann

EVP and General Counsel
Stoughton, MA

Track Institutional and Insider Activities on COLL

Follow COLLEGIUM PHARMACEUTICAL, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells COLL shares.

Notify only if

Insider Trading

Get notified when an Collegium Pharmaceutical, Inc insider buys or sells COLL shares.

Notify only if

News

Receive news related to COLLEGIUM PHARMACEUTICAL, INC

Track Activities on COLL